Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension

Background. The interest in mass screening programs for the early detection of endometrial cancer (EC) has grown with the rising incidence of this disease. Preliminary programs directed at asymptomatic women with only one risk factor, i.e. age, have not been cost‐effective. Methods. In the current s...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 71; no. 4; pp. 1279 - 1282
Main Authors Grönroos, Matti, Salmi, Tuula A., Vuento, Maarit H., Jalava, E. Anneli, Tyrkkö, Juhani E., Maatela, Jouni I., Aromaa, Arpo R., Siegberg, Rita, Savolainen, Eeva R., Kauraniemi, Tapani V.
Format Journal Article
LanguageEnglish
Published New York Wiley Subscription Services, Inc., A Wiley Company 15.02.1993
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background. The interest in mass screening programs for the early detection of endometrial cancer (EC) has grown with the rising incidence of this disease. Preliminary programs directed at asymptomatic women with only one risk factor, i.e. age, have not been cost‐effective. Methods. In the current study, 597 asymptomatic women from 45‐69 years of age with diabetes and/or hypertension were screened by Vabra (Berkeley Medevices Inc., Berkeley, CA) aspiration. Results. Among the women with diabetes, 6.3% preinvasive lesions of the endometrium were found. This is significantly more than the rate among women with hypertension, which was 1.3% (P > 0.01). Conclusions. Regular mass screening programs for the early detection of EC should be directed at asymptomatic diabetic women 45 years of age or older. This study does not indicate that similar screenings would be effective for women with hypertension.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(19930215)71:4<1279::AID-CNCR2820710418>3.0.CO;2-4